The DOI matches its Crossref record; 296 of the 296 references it cites were found in a registry or an index.
Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alvarez, F., Berg, P. A., Bianchi, F. B., Bianchi, L., Burroughs, A. K., Cancado, E. L., Chapman, R. W., Cooksley, W. G. E., Czaja, A. J., Desmet, V. J., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80297-9 · Cited by 2,903
Self-citationSimplified criteria for the diagnosis of autoimmune hepatitis
Hennes, E. M., Zeniya, M., Czaja, A. J., Parés, A., Dalekos, G. N., Krawitt, E. L., Bittencourt, P. L., Porta, G., Boberg, K. M., Hofer, H., et al. (2008) · Hepatology · doi:10.1002/hep.22322 · Cited by 1,901
Self-citationDiagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationMycophenolate mofetil and its mechanisms of action
Allison, A. C., & Eugui, E. M. (2000) · Immunopharmacology · doi:10.1016/s0162-3109(00)00188-0 · Cited by 1,433
Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus
Herold, K. C., Hagopian, W., Auger, J. A., Poumian-Ruiz, E., Taylor, L., Donaldson, D., Gitelman, S. E., Harlan, D. M., Xu, D., Zivin, R. A., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012864 · Cited by 1,222
Smith, C. A., Williams, G. T., Kingston, R., Jenkinson, E. J., & Owen, J. J. T. (1989) · Nature · doi:10.1038/337181a0 · Cited by 1,133
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes
Keymeulen, B., Vandemeulebroucke, E., Ziegler, A. G., Mathieu, C., Kaufman, L., Hale, G., Gorus, F., Goldman, M., Walter, M., Candon, S., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043980 · Cited by 1,099
Hodi, F. S., Mihm, M. C., Soiffer, R. J., Haluska, F. G., Butler, M., Seiden, M. V., Davis, T., Henry-Spires, R., MacRae, S., Willman, A., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0830997100 · Cited by 1,006
Soloway, R. D., Summerskill, W. H. J., Baggenstoss, A. H., Geall, M. G., Gitnick, G. L., Elveback, L. R., & Schoenfield, L. J. (1972) · Gastroenterology · doi:10.1016/s0016-5085(19)33223-8 · Cited by 779
Chazouillères, O., Wendum, D., Serfaty, L., Montembault, S., Rosmorduc, O., & Poupon, R. (1998) · Hepatology · doi:10.1002/hep.510280203 · Cited by 746
Gregorio, G. (2001) · Hepatology · doi:10.1053/jhep.2001.22131 · Cited by 692
Autoimmune Hepatitis in Childhood: A 20–Year Experience
Gregorio, G. V., Portmann, B., Reid, F., Donaldson, P. T., Doherty, D. G., McCartney, M., Mowat, A. P., Vergani, D., & Mieli-Vergani, G. (1997) · Hepatology · doi:10.1002/hep.510250308 · Cited by 665
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
Chatenoud, L., Thervet, E., Primo, J., & Bach, J. F. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.1.123 · Cited by 664
Identification of target antigen for SLA/LP autoantibodies in autoimmune hepatitis
Wies, I., Brunner, S., Henninger, J., Herkel, J., Kanzler, S., zum Büschenfelde, K.-H. M., & Lohse, A. W. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02166-8 · Cited by 636
Herold, K. C., Gitelman, S. E., Masharani, U., Hagopian, W., Bisikirska, B., Donaldson, D., Rother, K., Diamond, B., Harlan, D. M., & Bluestone, J. A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1763 · Cited by 634
Molecular mimicry and immune‐mediated diseases
Oldstone, M. B. A. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.13.1255 · Cited by 599
Homberg, J.-C., Abuaf, N., Bernard, O., Islam, S., Alvarez, F., Khalil, S. H., Poupon, R., Darnis, F., Lévy, V.-G., Grippon, P., et al. (1987) · Hepatology · doi:10.1002/hep.1840070626 · Cited by 576
Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis
COOK, G. C., MULLIGAN, R., & SHERLOCK, S. (1971) · QJM · doi:10.1093/oxfordjournals.qjmed.a067264 · Cited by 564
Pociot, F., Briant, L., Jongeneel, C. V., Mölvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J., & Cambon‐Thomsen, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230135 · Cited by 548
Lapierre, P., Hajoui, O., Homberg, J.-C., & Alvarez, F. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70186-1 · Cited by 538
Molecular Mimicry and Autoimmunity
Albert, L. J., & Inman, R. D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912303412707 · Cited by 516
Fedorak, R. N., Gangl, A., Elson, C. O., Rutgeerts, P., Schreiber, S., Wild, G., Hanauer, S. B., Kilian, A., Cohard, M., LeBeaut, A., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20229 · Cited by 512
Acute hepatic allograft rejection: Incidence, risk factors, and impact on outcome †
Wiesner, R. H., Demetris, J. A., Belle, S. H., Seaberg, E. C., Lake, J. R., Zetterman, R. K., Everhart, J., & Detre, K. M. (1998) · Hepatology · doi:10.1002/hep.510280306 · Cited by 495
CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS
Murray-Lyon, I., Stern, R. B., & Williams, R. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92125-9 · Cited by 468
Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease
Schreiber, S., Fedorak, R. N., Nielsen, O. H., Wild, G., Williams, C. N., Nikolaus, S., Jacyna, M., Lashner, B. A., Gangl, A., Rutgeerts, P., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.20196 · Cited by 458
Manns, M. P., Griffin, K. J., Sullivan, K. F., & Johnson, E. F. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115443 · Cited by 456
Self-citationTransplantation of Anergic Histoincompatible Bone Marrow Allografts
Guinan, E. C., Boussiotis, V. A., Neuberg, D., Brennan, L. L., Hirano, N., Nadler, L. M., & Gribben, J. G. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906033402202 · Cited by 429
Manns, M., Kyriatsoulis, A., Gerken, G., Staritz, M., Meyer, K. H., & Büschenfelde, Z. (1987) · The Lancet · doi:10.1016/s0140-6736(87)92024-1 · Cited by 424
Self-citationDe-novo autoimmune hepatitis after liver transplantation
Kerkar, N., Hadzic, N., Davies, E. T., Portmann, B., Donaldson, P. T., Rela, M., Heaton, N. D., Vergani, D., & Mieli-Vergani, G. (1998) · The Lancet · doi:10.1016/s0140-6736(97)06478-7 · Cited by 413
Impairment of CD4+CD25+ regulatory T-cells in autoimmune liver disease
Longhi, M. S., Ma, Y., Bogdanos, D. P., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.03.008 · Cited by 405
Donaldson, P. T., Doherty, D. G., Hayllar, K. M., McFarlane, I. G., Johnson, P. J., & Williams, R. (1991) · Hepatology · doi:10.1002/hep.1840130415 · Cited by 389
CD3-specific antibodies: a portal to the treatment of autoimmunity
Chatenoud, L., & Bluestone, J. A. (2007) · Nature Reviews Immunology · doi:10.1038/nri2134 · Cited by 388
Azathioprine for Long-Term Maintenance of Remission in Autoimmune Hepatitis
Johnson, P. J., McFarlane, I. G., & Williams, R. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510123331502 · Cited by 382
Autoimmune Hepatitis: Effect of Symptoms and Cirrhosis on Natural History and Outcome *
Feld, J. J., Dinh, H., Arenovich, T., Marcus, V. A., Wanless, I. R., & Heathcote, J. E. (2005) · Hepatology · doi:10.1002/hep.20732 · Cited by 367
Manns, M. P., Johnson, E. F., Griffin, K. J., Tan, E. M., & Sullivan, K. F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci113949 · Cited by 363
Self-citationSummerskill, W. H., Korman, M. G., Ammon, H. V., & Baggenstoss, A. H. (1975) · Gut · doi:10.1136/gut.16.11.876 · Cited by 352
Structural basis for co-stimulation by the human CTLA-4/B7-2 complex
Schwartz, J.-C. D., Zhang, X., Fedorov, A. A., Nathenson, S. G., & Almo, S. C. (2001) · Nature · doi:10.1038/35069112 · Cited by 349
Nelson, D. R., Lauwers, G. Y., Lau, J. Y. N., & Davis, G. L. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70134-x · Cited by 349
Frequency and nature of the variant syndromes of autoimmune liver disease
Czaja, A. J. (1998) · Hepatology · doi:10.1002/hep.510280210 · Cited by 343
Self-citationFunctional Study of CD4+CD25+ Regulatory T Cells in Health and Autoimmune Hepatitis
Longhi, M. S., Hussain, M. J., Mitry, R. R., Arora, S. K., Mieli-Vergani, G., Vergani, D., & Ma, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.7.4484 · Cited by 323
CD3-specific antibody-induced active tolerance: from bench to bedside
Chatenoud, L. (2003) · Nature Reviews Immunology · doi:10.1038/nri1000 · Cited by 309
Liver‐targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis†
Lan, R. Y., Cheng, C., Lian, Z., Tsuneyama, K., Yang, G., Moritoki, Y., Chuang, Y., Nakamura, T., Saito, S., Shimoda, S., et al. (2006) · Hepatology · doi:10.1002/hep.21123 · Cited by 305
Prognosis of histological cirrhosis in type 1 autoimmune hepatitis
Roberts, S., Therneau, T., & Czaja, A. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608895 · Cited by 299
Self-citationBresson, D. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27191 · Cited by 293
Lohse, A. W., zum Büschenfelde, K.-H. M., Franz, B., Kanzler, S., Gerken, G., & Dienes, H.-P. (1999) · Hepatology · doi:10.1002/hep.510290409 · Cited by 278
Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis
Strettell, M., Donaldson, P., Thomson, L., Santrach, P., Moore, S., Czaja, A., & Williams, R. (1997) · Gastroenterology · doi:10.1053/gast.1997.v112.pm9178696 · Cited by 277
Self-citationMa, Y., Okamoto, M., Thomas, M. G., Bogdanos, D. P., Lopes, A. R., Portmann, B., Underhill, J., Dürr, R., Mieli-Vergani, G., & Vergani, D. (2002) · Hepatology · doi:10.1053/jhep.2002.32092 · Cited by 271
Prevalence of autoimmune liver disease in Alaska natives
Hurlburt, K. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)04376-9 · Cited by 265
Associations Between Alleles of the Major Histocompatibility Complex and Type 1 Autoimmune Hepatitis
Czaja, A. J., Strettell, M. D., Thomson, L. J., Santrach, P. J., Moore, S. B., Donaldson, P. T., & Williams, R. (1997) · Hepatology · doi:10.1002/hep.510250211 · Cited by 264
Self-citationFerran, C., Sheehan, K., Dy, M., Schreiber, R., Merite, S., Landais, P., Noel, L., Grau, G., Bluestone, J., Bach, J., et al. (1990) · European Journal of Immunology · doi:10.1002/eji.1830200308 · Cited by 264
Vogel, A., Strassburg, C. P., & Manns, M. P. (2002) · Hepatology · doi:10.1053/jhep.2002.30084 · Cited by 259
Self-citationManagement and outcome of pregnancy in autoimmune hepatitis
Heneghan, M. A., Norris, S. M., O'Grady, J. G., Harrison, P. M., & McFarlane, I. G. (2001) · Gut · doi:10.1136/gut.48.1.97 · Cited by 253
Strassburg, C. P., Kneip, S., Topp, J., Obermayer-Straub, P., Barut, A., Tukey, R. H., & Manns, M. P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002180200 · Cited by 249
Self-citationIchai, P., Duclos-Vallée, J.-C., Guettier, C., Hamida, S. B., Antonini, T., Delvart, V., Saliba, F., Azoulay, D., Castaing, D., & Samuel, D. (2007) · Liver Transplantation · doi:10.1002/lt.21036 · Cited by 249
Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis
Czaja, A. J., & Carpenter, H. A. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.01.009 · Cited by 248
Self-citationAgarwal, K., Czaja, A. J., Jones, D. E., & Donaldson, P. T. (2000) · Hepatology · doi:10.1002/hep.510310110 · Cited by 244
Self-citationEffect of CD4+CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis
Longhi, M. S., Ma, Y., Mitry, R. R., Bogdanos, D. P., Heneghan, M., Cheeseman, P., Mieli-Vergani, G., & Vergani, D. (2005) · Journal of Autoimmunity · doi:10.1016/j.jaut.2005.05.001 · Cited by 237
Interleukin–10 Expression and Function in Experimental Murine Liver Inflammation and Fibrosis
Thompson, K., Maltby, J., Fallowfield, J., McAulay, M., Millward-Sadler, H., & Sheron, N. (1998) · Hepatology · doi:10.1002/hep.510280620 · Cited by 236
Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome
Floreani, A., Rizzotto, E. R., Ferrara, F., Carderi, I., Caroli, D., Blasone, L., & Baldo, V. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41841.x · Cited by 230
Non-treatment of defective newborn babies.
SILVERMAN, W. A. (1980) · PubMed · Cited by 227
Performance parameters of the diagnostic scoring systems for autoimmune hepatitis
Czaja, A. J. (2008) · Hepatology · doi:10.1002/hep.22513 · Cited by 221
Self-citationAntibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2
Martini, E., Abuaf, N., Cavalli, F., Durand, V., Johanet, C., & Homberg, J.-C. (1988) · Hepatology · doi:10.1002/hep.1840080632 · Cited by 220
Pando, M., Larriba, J., Fernandez, G. C., Fainboim, H., Ciocca, M., Ramonet, M., Badia, I., Daruich, J., Findor, J., Tanno, H., et al. (1999) · Hepatology · doi:10.1002/hep.510300611 · Cited by 219
Doherty, D. G., Donaldson, P. T., Underhill, J. A., Farrant, M. J., Duthie, A., Mieli-Vergani, G., McFarlane, I. G., Johnson, P. J., Eddleston, A. L. W. F., Mowat, A. P., et al. (1994) · Hepatology · doi:10.1002/hep.1840190311 · Cited by 219
Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis
Kessler, W. R., Cummings, O. W., Eckert, G., Chalasani, N., Lumeng, L., & Kwo, P. Y. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00246-0 · Cited by 216
Czaja, A. J., Manns, M. P., & Homburger, H. A. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)91518-9 · Cited by 214
Self-citationTRANSFUSION ASSOCIATED GRAFT-VERSUS-HOST DISEASE IN AUTOLOGOUS BONE MARROW TRANSPLANTATION
Mulder, N. H., Elema, J. D., & Postmus, P. E. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92261-7 · Cited by 211
Kerkar, N., Choudhuri, K., Ma, Y., Mahmoud, A., Bogdanos, D. P., Muratori, L., Bianchi, F., Williams, R., Mieli-Vergani, G., & Vergani, D. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1481 · Cited by 208
Ma, Y., Bogdanos, D. P., Hussain, M. J., Underhill, J., Bansal, S., Longhi, M. S., Cheeseman, P., Mieli–Vergani, G., & Vergani, D. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.12.020 · Cited by 207
Bourdi, M., Larrey, D., Nataf, J., Bernuau, J., Pessayre, D., Iwasaki, M., Guengerich, F. P., & Beaune, P. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114660 · Cited by 207
Significance of HLA DR4 in type 1 autoimmune hepatitis
Czaja, A. J., Carpenter, H. A., Santrach, P. J., & Moore, S. B. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90157-8 · Cited by 206
Self-citationNelson, D. R., Tu, Z., Soldevila-Pico, C., Abdelmalek, M., Zhu, H., Xu, Y. L., Cabrera, R., Liu, C., & Davis, G. L. (2003) · Hepatology · doi:10.1002/hep.1840380412 · Cited by 202
Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis.
Lidman, K., Biberfeld, G., Fagraeus, A., Norberg, R., Torstensson, R., Utter, G., Carlsson, L., Luca, J., & Lindberg, U. (1976) · PubMed · Cited by 201
Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis
Czaja, A. J., & Donaldson, P. T. (2000) · Immunological Reviews · doi:10.1034/j.1600-0528.2002.017401.x · Cited by 201
Self-citationDuclos-Vallée, J.-C., Sebagh, M., Rifai, K., Johanet, C., Ballot, E., Guettier, C., Karam, V, Hurtova, M., Feray, C., Reynes, M., et al. (2003) · Gut · doi:10.1136/gut.52.6.893 · Cited by 201
Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly
Czaja, A. J., & Carpenter, H. A. (2006) · Hepatology · doi:10.1002/hep.21074 · Cited by 200
Self-citationHirsch, R., Gress, R. E., Pluznik, D. H., Eckhaus, M., & Bluestone, J. A. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.3.737 · Cited by 199
HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients
Seki, T., Ota, M., Furuta, S., Fukushima, H., Kondo, T., Hino, K., Mizuki, N., Ando, A., Tsuji, K., Inoko, H., et al. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90041-v · Cited by 198
Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection
Holdener, M., Hintermann, E., Bayer, M., Rhode, A., Rodrigo, E., Hintereder, G., Johnson, E. F., Gonzalez, F. J., Pfeilschifter, J., Manns, M. P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071859 · Cited by 196
Self-citationThe validity and importance of subtypes in autoimmune hepatitis: a point of view.
Czaja, A. J., & Manns, M. P. (1995) · PubMed · Cited by 194
Self-citationRecurrent autoimmune hepatitis after orthotopic liver transplantation
González-Koch, A., Czaja, A. J., Carpenter, H. A., Roberts, S. K., Charlton, M. R., Porayko, M. K., Rosen, C. B., & Wiesner, R. H. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.21449 · Cited by 193
Self-citationAutoimmune hepatitis with incidental histologic features of bile duct injury
Czaja, A. J., & Carpenter, H. A. (2001) · Hepatology · doi:10.1053/jhep.2001.27562 · Cited by 189
Self-citationFrequency and Significance of Antibodies to Actin in Type 1 Autoimmune Hepatitis
Czaja, A. J., Cassani, F., Cataleta, M., Valentini, P., & Bianchi, F. B. (1996) · Hepatology · doi:10.1002/hep.510240515 · Cited by 189
Self-citationMycophenolate Mofetil as Second Line Therapy in Autoimmune Hepatitis?
Hennes, E. M., Oo, Y. H., Schramm, C., Denzer, U., Buggisch, P., Wiegard, C., Kanzler, S., Schuchmann, M., Boecher, W., Galle, P. R., et al. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02180.x · Cited by 188
Ratziu, V., Samuel, D., Sebagh, M., Farges, O., Saliba, F., Ichai, P., Farahmand, H., Gigou, M., Féray, C., Reynès, M., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80017-8 · Cited by 188
Classification of smooth muscle autoantibodies detected by immunofluorescence.
Bottazzo, G. F., Florin-Christensen, A., Fairfax, A., Swana, G., Doniach, D., & Groeschel-Stewart, U. (1976) · Journal of Clinical Pathology · doi:10.1136/jcp.29.5.403 · Cited by 184
Baeres, M., Herkel, J., Czaja, A. J., Wies, I., Kanzler, S., Cancado, E. L. R., Porta, G., Nishioka, M., Simon, T., Daehnrich, C., et al. (2002) · Gut · doi:10.1136/gut.51.2.259 · Cited by 184
Self-citationThiel, D. H. V., Wright, H. I., Carroll, P. B., Abu-Elmagd, K. M., Rodriguez-Rilo, H. L., McMichael, J., Irish, W. D., & Starzl, T. E. (1995) · PubMed · Cited by 183
Sanchez-Urdazpal, L., Czaja, A. J., van Hoek, B., Krom, R. A. F., & Wiesner, R. H. (1992) · Hepatology · doi:10.1002/hep.1840150208 · Cited by 183
Self-citationImprovement of autoimmune hepatitis during pregnancy followed by flare-up after delivery
Buchel, E. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(02)05541-7 · Cited by 181
Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis
Cookson, S., Constantini, P. K., Clare, M., Underhill, J. A., Bernal, W., Czaja, A. J., & Donaldson, P. T. (1999) · Hepatology · doi:10.1002/hep.510300412 · Cited by 180
Self-citationMolecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences
Bogdanos, D., Choudhuri, K., & Vergani, D. (2001) · Liver · doi:10.1034/j.1600-0676.2001.021004225.x · Cited by 177
Yeoman, A. D., Westbrook, R. H., Al‐Chalabi, T., Carey, I., Heaton, N. D., Portmann, B. C., & Heneghan, M. A. (2009) · Hepatology · doi:10.1002/hep.23042 · Cited by 177
CTLA‐4: a key regulatory point in the control of autoimmune disease
Scalapino, K. J., & Daikh, D. I. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00639.x · Cited by 176
CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis
Agarwal, K., Jones, D. E. J., Daly, A. K., James, O. F. W., Vaidya, B., Pearce, S., & Bassendine, M. F. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80213-5 · Cited by 176
Response to steroids in de novo autoimmune hepatitis after liver transplantation
Salcedo, M., Vaquero, J., Bañares, R., Rodríguez-Mahou, M., Alvarez, E., Vicario, J. L., Hernández-Albújar, A., Tíscar, J. L. R., Rincón, D., Alonso, S., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.31167 · Cited by 176
Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2
Bittencourt, P. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(99)00285-3 · Cited by 176
Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis
Gohlke, F., Lohse, A. W., Dienes, H. P., Löhr, H., Märker-Hermann, E., Gerken, G., & Meyer zum Büschenfelde, K.-H. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80266-2 · Cited by 175
Czaja, A. J., Cookson, S., Constantini, P. K., Clare, M., Underhill, J. A., & Donaldson, P. T. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70458-0 · Cited by 171
Self-citationCzaja, A. J., Menon, N. K. V., & Carpenter, H. A. (2002) · Hepatology · doi:10.1053/jhep.2002.32485 · Cited by 171
Self-citationMontano-Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01153.x · Cited by 170
Self-citationPerdigoto, R., Carpenter, H. A., & Czaja, A. J. (1992) · Journal of Hepatology · doi:10.1016/0168-8278(92)90178-r · Cited by 168
Self-citationRacial disparity in liver disease: Biological, cultural, or socioeconomic factors
Nguyen, G. C., & Thuluvath, P. J. (2008) · Hepatology · doi:10.1002/hep.22223 · Cited by 165
Czaja, A. J., Davis, G. L., Ludwig, J., & Taswell, H. F. (1984) · Hepatology · doi:10.1002/hep.1840040409 · Cited by 163
Self-citationThe clinical utility of inhibiting CD28‐mediated costimulation
Linsley, P. S., & Nadler, S. G. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00780.x · Cited by 162
Autoimmune Hepatitis Overlapping With Primary Sclerosing Cholangitis in Five Cases
McNair, A., Moloney, M. M., Portmann, B. C., Williams, R. L., & McFarlane, I. G. (1998) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1998.224_a.x · Cited by 159
Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults
Heneghan, M. A., Portmann, B. C., Norris, S. M., Williams, R. L., Muiesan, P., Rela, M., Heaton, N. D., & O’Grady, J. G. (2001) · Hepatology · doi:10.1053/jhep.2001.26756 · Cited by 156
Kammer, A. R., van der Burg, S. H., Grabscheid, B., Hunziker, I. P., Kwappenberg, K. M. C., Reichen, J., Melief, C. J. M., & Cerny, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.2.169 · Cited by 156
Cyclosporine Therapy in Patients With Steroid Resistant Autoimmune Hepatitis
Fernandes, N. F., Redeker, A. G., Vierling, J. M., Villamil, F. G., & Fong, T. (1999) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.00807.x · Cited by 155
A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens
Lapierre, P., Djilali-Saiah, I., Vitozzi, S., & Álvarez, F. (2004) · Hepatology · doi:10.1002/hep.20109 · Cited by 154
Pathogenesis of autoimmune hepatitis
Vergani, D., Choudhuri, K., Bogdanos, D. P., & Mieli‐Vergani, G. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00018-1 · Cited by 153
Costa, M., Rodríguez-Sánchez, J. L., Czaja, A. J., & Gelpí, C. (2000) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2000.01280.x · Cited by 152
Self-citationMontaño‐Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2007) · Hepatology · doi:10.1002/hep.21787 · Cited by 150
Self-citationGelpí, C., Sontheimer, E. J., & Rodriguez-Sanchez, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.20.9739 · Cited by 150
Flóres, Y. N., Yee, H. F., Leng, M., Escarce, J. J., Bastani, R., Salmerón, J., & Morales, L. S. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.02022.x · Cited by 150
Czaja, A. J., Donaldson, P. T., & Lohse, A. W. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05479.x · Cited by 147
Self-citationLong‐term outcome of liver transplantation for autoimmune hepatitis
Vogel, A., Heinrich, E., Bahr, M. J., Rifai, K., Flemming, P., Melter, M., Klempnauer, J., Nashan, B., Manns, M. P., & Strassburg, C. P. (2004) · Clinical Transplantation · doi:10.1111/j.1399-0012.2004.00117.x · Cited by 147
Self-citationSmooth muscle autoantibodies and autoantigens.
Bh, T. (1979) · PubMed Central · Cited by 146
Long-term management and prognosis of autoimmune hepatitis (AIH): A single center experience
Kanzler, S., Löhr, H. F., Gerken, G., Galle, P. R., & Lohse, A. W. (2001) · Zeitschrift für Gastroenterologie · doi:10.1055/s-2001-13708 · Cited by 145
Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis
Stechemesser, E., Klein, R., & Berg, P. A. (1993) · Hepatology · doi:10.1002/hep.1840180102 · Cited by 145
Mistilis, S. P., SKYRING, A. P., & BLACKBURN, C. R. B. (1968) · Australasian Annals of Medicine · doi:10.1111/imj.1968.17.3.214 · Cited by 144
Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis
Nakamura, K., Yoneda, M., Yokohama, S., Tamori, K., Sato, Y., Aso, K., Aoshima, M., Hasegawa, T., & MAKING, I. (1998) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1998.tb00674.x · Cited by 143
Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent.
Crivelli, O., Lavarini, C., Chiaberge, E., Amoroso, A., Farci, P., Negro, F., & Rizzetto, M. (1983) · PubMed Central · Cited by 143
Oral budesonide for treatment of autoimmune chronic active hepatitis
Danielsson, A., & Prytz, H. (1994) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1994.tb00334.x · Cited by 142
MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis
García, M. N. V., Alaez, C., Olivo, A., Hector, D., Pérez-Luque, E. L., Burguete-García, A. I., Cano, S., de la Rosa, G., Bautista, N., Hernández, A., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80347-4 · Cited by 141
Fainboim, L., Velasco, M., Marcos, C. Y., Ciocca, M. E., Roy, A. H., Theiler, G., Capucchio, M., Nuncifora, S., Sala, L., & Zelazko, M. (2001) · Hepatology · doi:10.1053/jhep.2001.24562 · Cited by 141
Hofer, H., Oesterreicher, C., Wrba, F., Ferenci, P., & Penner, E. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.029348 · Cited by 140
The impact of ethnicity on the natural history of autoimmune hepatitis
Verma, S., Torbenson, M. S., & Thuluvath, P. J. (2007) · Hepatology · doi:10.1002/hep.21884 · Cited by 139
Efficacy of Tacrolimus in the Treatment of Steroid Refractory Autoimmune Hepatitis
Aqel, B. A., Machicao, V. I., Rosser, B. G., Satyanarayana, R., Harnois, D. M., & Dickson, R. C. (2004) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000139050.67178.be · Cited by 138
Czaja, A. J., Wolf, A. M., & Baggenstoss, A. H. (1981) · Gastroenterology · doi:10.1016/0016-5085(81)90126-8 · Cited by 137
Self-citationRapamycin Successfully Treats Post-Transplant Autoimmune Hepatitis
Kerkar, N. N., Dugan, C. A., Rumbo, C., Morotti, R. A., Gondolesi, G. E., Shneider, B. L., & Emre, S. (2005) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2005.00801.x · Cited by 137
Czaja, A. J., Souto, E. O., Bittencourt, P. L., Cançado, E. L. R., Porta, G., Goldberg, A. C., & Donaldson, P. T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00182-4 · Cited by 136
Self-citationPhilipp, T., Durazzo, M., Trautwein, C., Alex, B., Manns, M. P., Durazzo, M., Straub, P., Lamb, J. G., Tukey, R. H., & Ef, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91966-6 · Cited by 135
Self-citationAbdalian, R., Dhar, P., Jhaveri, K. S., Haider, M. A., Guindi, M. M., & Heathcote, J. (2008) · Hepatology · doi:10.1002/hep.22073 · Cited by 134
Stellon, A. J., Keating, J. J., Johnson, P. J., McFarlane, I. G., & Williams, R. L. (1988) · Hepatology · doi:10.1002/hep.1840080414 · Cited by 134
Cyclosporin A Is a Promising Alternative to Corticosteroids in Autoimmune Hepatitis
Malekzadeh, R., Nasseri‐Moghaddam, S., Kaviani, M. J., Taheri, H., Kamalian, N., & Sotoudeh, M. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010683817344 · Cited by 131
Validation of scoring system for diagnosis of autoimmune hepatitis
Czaja, A. J., & Carpenter, H. A. (1996) · Digestive Diseases and Sciences · doi:10.1007/bf02093820 · Cited by 131
Self-citationPharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers*
Huhn, R. D., Radwanski, E., Gallo, J., Affrime, M. B., Sabo, R., Gonyo, G., Monge, A., & Cutler, D. L. (1997) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(97)90065-5 · Cited by 131
Prognosis of Symptomatic Versus Asymptomatic Autoimmune Hepatitis
Kogan, J., Safadi, R., Ashur, Y., Shouval, D., & Ilan, Y. (2002) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-200207000-00016 · Cited by 130
Czaja, A. J., Ammon, H. V., & Summerskill, W. H. J. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90866-5 · Cited by 130
Self-citationAutoantibodies and their Antigens in Autoimmune Hepatitis
Bogdanos, D. P., Mieli‐Vergani, G., & Vergani, D. (2009) · Seminars in Liver Disease · doi:10.1055/s-0029-1233533 · Cited by 129
Heneghan, M. A., Allan, M. L., Bornstein, J. D., Muir, A. J., & Tendler, D. A. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.05.011 · Cited by 128
Fan, L., Tu, X.-Q., Zhu, Y., Zhou, L., PFEIFFER, T., Feltens, R., Stoecker, W., & Zhong, R. (2005) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2005.03532.x · Cited by 127
Consequences of treatment withdrawal in type 1 autoimmune hepatitis
Montaño‐Loza, A. J., Carpenter, H. A., & Czaja, A. J. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01444.x · Cited by 126
Self-citationIgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis
Umemura, T., Zen, Y., Hamano, H., Ichijo, T., Kawa, S., Nakanuma, Y., & Kiyosawa, K. (2007) · Gut · doi:10.1136/gut.2007.122283 · Cited by 126
Long-term follow-up of chronic active hepatitis of moderate severity.
de Groote, J., Fevery, J., & Lepoutre, L. (1978) · Gut · doi:10.1136/gut.19.6.510 · Cited by 125
Cross, T., Antoniades, C. G., Muiesan, P., Al–Chalabi, T., Aluvihare, V. R., Agarwal, K., Portmann, B. C., Rela, M., Heaton, N. D., O’Grady, J. G., et al. (2007) · Liver Transplantation · doi:10.1002/lt.21181 · Cited by 124
Longhi, M. S., Meda, F., Wang, P., Samyn, M., Mieli‐Vergani, G., Vergani, D., & Ma, Y. (2008) · Hepatology · doi:10.1002/hep.22071 · Cited by 124
Larsen, F. S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i23.3232 · Cited by 124
Czaja, A. J., Ludwig, J., Baggenstoss, A. H., & Wolf, A. M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198101013040102 · Cited by 124
Self-citationFailure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis
Czaja, A. J., & Lindor, K. D. (2000) · Gastroenterology · doi:10.1053/gast.2000.0010000001 · Cited by 123
Self-citationCzaja, A. J., Nishioka, M., MORSHED, S. A., & Hachiya, T. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90078-7 · Cited by 122
Self-citationHepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy
Obermayer–Straub, P., Perheentupa, J., Braun, S., Kayser, A., Barut, A., Loges, S., Harms, A., Dalekos, G., Strassburg, C. P., & Manns, M. P. (2001) · Gastroenterology · doi:10.1053/gast.2001.27103 · Cited by 122
Self-citationAw, M., Dhawan, A. K., Samyn, M., Bargiota, A., & Mieli‐Vergani, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.024 · Cited by 121
Czaja, A. J., Rakela, J. L., & Ludwig, J. (1988) · Gastroenterology · doi:10.1016/0016-5085(88)90503-3 · Cited by 120
Self-citationChronic active autoimmune hepatitis in children
Fainboim, L., Marcos, C. Y., Pando, M. J., Capucchio, M., Reyes, G. B., Galoppo, C., Badia, I. B., Remondino, G., Ciocca, M. E., Ramonet, M., et al. (1994) · Human Immunology · doi:10.1016/0198-8859(94)90008-6 · Cited by 120
Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis
Fernandes, N. (1999) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(98)00688-1 · Cited by 119
Muratori, L., Cataleta, M., Muratori, P., Lenzi, M., & Bianchi, F. B. (1998) · Gut · doi:10.1136/gut.42.5.721 · Cited by 118
Clemente, M. G., Meloni, A., Obermayer–Straub, P., Frau, F., Manns, M. P., & Virgiliis, S. D. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70484-6 · Cited by 118
Self-citationKorhonen, R., & Moilanen, E. (2009) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2009.00375.x · Cited by 117
Rapidity of treatment response and outcome in type 1 autoimmune hepatitis
Czaja, A. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.02.026 · Cited by 117
Self-citationAutoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis
Neuhauser, M., Bjornsson, E., Treeprasertsuk, S., Enders, F., Silveira, M., Talwalkar, J., & Lindor, K. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.616 · Cited by 116
Ludwig, J., Czaja, A. J., Dickson, E. R., LaRusso, N. F., & Wiesner, R. H. (1984) · Liver International · doi:10.1111/j.1600-0676.1984.tb00914.x · Cited by 116
Self-citationIdentification and characterization of IgG4-associated autoimmune hepatitis
Chung, H., Watanabe, T., Kudo, M., Maenishi, O., Wakatsuki, Y., & Chiba, T. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02092.x · Cited by 113
Manns, M. P., & Obermayer–Straub, P. (1997) · Hepatology · doi:10.1002/hep.510260438 · Cited by 113
Self-citationStraßburg, C., Obermayer–Straub, P., Alex, B., Durazzo, M., Rizzetto, M., Tukey, R. H., & Manns, M. (1996) · Gastroenterology · doi:10.1016/s0016-5085(96)70020-3 · Cited by 113
Self-citationEfficacy of cyclosporin A in children with type 2 autoimmune hepatitis
Debray, D., Maggiore, G., Girardet, J.-P., Mallet, E., & Bernard, O. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70339-2 · Cited by 112
Campsen, J., Zimmerman, M. A., Trotter, J. F., Wachs, M. E., Bak, T., Steinberg, T. G., Kaplan, M., Wright, F. L., & Kam, I. (2008) · Liver Transplantation · doi:10.1002/lt.21525 · Cited by 112
Abuaf, N., Johanet, C., Chrétien, P., Martini, E., Soulier, E., Laperche, S., & Homberg, J. C. (1992) · Hepatology · doi:10.1002/hep.1840160407 · Cited by 111
Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin
Zolfino, T., Heneghan, M. A., Norris, S., Harrison, P., Portmann, B. C., & McFarlane, I. G. (2002) · Gut · doi:10.1136/gut.50.5.713 · Cited by 111
Gregorio, G. V., Choudhuri, K., Yuan-fang Ma, A., Pensati, P., Iorio, R. F., Grant, P. R., Garson, J. A., Bogdanos, D. P., Vegnente, A., Mieli‐Vergani, G., et al. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02229.x · Cited by 111
Chatur, N., Ramji, A. S., Bain, V. G., Ma, M. M., Marotta, P. J., Ghent, C. N., Lilly, L., Heathcote, E. J., Deschênes, M., Lee, S. S., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01107.x · Cited by 111
Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis
Yoshizawa, K., Ôta, M., Katsuyama, Y., Ichijo, T., Matsumoto, A., Tanaka, E., & Kiyosawa, K. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.12.019 · Cited by 110
Safety issues in the management of autoimmune hepatitis
Czaja, A. J. (2008) · Expert Opinion on Drug Safety · doi:10.1517/14740338.7.3.319 · Cited by 109
Self-citationThe nature and prognosis of severe cryptogenic chronic active hepatitis
Czaja, A. J., Carpenter, H. A., Santrach, P. J., Moore, S. B., & Homburger, H. A. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90656-w · Cited by 108
Self-citationAbatacept for rheumatoid arthritis
Maxwell, L. J., & Singh, J. A. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007277.pub2 · Cited by 108
A Single Center Review of the Use of Mycophenolate Mofetil in the Treatment of Autoimmune Hepatitis
Hlivko, J. T., Shiffman, M. L., Stravitz, R. T., Luketic, V. A., Sanyal, A. J., Fuchs, M. A., & Sterling, R. K. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.04.006 · Cited by 107
Cytochrome P450 1A2 Is a Hepatic Autoantigen in Autoimmune Polyglandular Syndrome Type 1
Clemente, M. G., Obermayer–Straub, P., Meloni, A., Strassburg, C. P., Arangino, V., Tukey, R. H., Virgiliis, S. D., & Manns, M. P. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.5.3913 · Cited by 107
Self-citationSherman, K. E., Narkewicz, M. R., & Pinto, P. C. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(05)80615-4 · Cited by 106
Autoimmune hepatitis in African Americans: presenting features and response to therapy
Lim, K. N., Rl, C., BOYER, T. D., & Bruno, C. J. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.05272.x · Cited by 105
Devlin, S. M., Swain, M. G., Urbanski, S. J., & Burak, K. W. (2004) · Canadian Journal of Gastroenterology · doi:10.1155/2004/504591 · Cited by 105
Budesonide in previously untreated autoimmune hepatitis
Wiegand, J., Schüler, A., Kanzler, S., Lohse, A. W., Beuers, U. H., Kreisel, W., Spengler, U., Koletzko, S., Jansen, P. L. M., Hochhaus, G., et al. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01122.x · Cited by 103
Self-citationAntibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis
Ballot, E., Homberg, J. C., & Johanet, C. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80361-x · Cited by 102
Cyclosporine treatment of autoimmune chronic active hepatitis
Hyams, J. S., Ballow, M. C., & Leichtner, A. M. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90454-9 · Cited by 102
Biopsy Findings and Clinical Correlations
Burgart, L. J., Batts, K. P., Ludwig, J., Nikias, G. A., & Czaja, A. J. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199506000-00010 · Cited by 101
Self-citationGenetic Factors Affecting the Occurrence, Clinical Phenotype, and Outcome of Autoimmune Hepatitis
Czaja, A. J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.12.048 · Cited by 99
Self-citationThe regulatory effect of natural killer cells: do "NK-reg cells" exist?
Zhang, C., Zhang, J., & Tian, Z. (2006) · PubMed · Cited by 98
P2X7 Receptors Regulate NKT Cells in Autoimmune Hepatitis
Kawamura, H., Aswad, F., Minagawa, M., Govindarajan, S., & Dennert, G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.4.2152 · Cited by 98
Autoimmune Hepatitis With Centrilobular Necrosis
Misdraji, J., Thiim, M., & Graeme‐Cook, F. (2004) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200404000-00006 · Cited by 98
HLA Class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis
Djilali-Saiah, I., Fakhfakh, A., Louafi, H., Caillat‐Zucman, S., Debray, D., & Álvarez, F. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.07.034 · Cited by 98
Features and consequences of untreated type 1 autoimmune hepatitis
Czaja, A. J. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01904.x · Cited by 97
Self-citationClinicopathological features of acute-onset autoimmune hepatitis
Okano, N., Yamamoto, K., Sakaguchi, K., Miyake, Y., Shimada, N., Hakoda, T., Terada, R., Baba, S., Suzuki, T., & Tsuji, T. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00274-7 · Cited by 97
Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis
Granito, A., Muratori, L., Muratori, P., Παππάς, Γ., Guidi, M., Cassani, F., Volta, U., Ferri, A., Lenzi, M., & Bianchi, F. B. (2006) · Journal of Clinical Pathology · doi:10.1136/jcp.2005.027367 · Cited by 97
Recurrence of Autoimmune Hepatitis in Children After Liver Transplantation
Birnbaum, A. H., Benkov, K. J., Pittman, N. S., McFarlane‐Ferreira, Y., Rosh, J. R., & LeLeiko, N. S. (1997) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199707000-00003 · Cited by 94
Doherty, D. G., Penzotti, J. E., Koelle, D. M., Kwok, W. W., Lybrand, T. P., Masewicz, S., & Nepom, G. T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3527 · Cited by 92
Clinical, hematologic, and immunologic effects of interleukin-10 in humans
Fuchs, A. C., Granowitz, E. V., Shapiro, L., Vannier, E. G., Lonnemann, G., Angel, J. B., Kennedy, J. S., Rabson, A. R., Radwanski, E., Affrime, M. B., et al. (1996) · Journal of Clinical Immunology · doi:10.1007/bf01541395 · Cited by 90
Autoimmune hepatitis. Part A: pathogenesis
Czaja, A. J. (2007) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.1.1.113 · Cited by 90
Self-citationCzaja, A. J., Beaver, S. J., & Shiels, M. T. (1987) · Gastroenterology · doi:10.1016/0016-5085(87)90862-6 · Cited by 89
Self-citationLangley, P. G., Underhill, J. A., Tredger, J. M., Norris, S., & McFarlane, I. G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00214-3 · Cited by 89
Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis
Czaja, A. J., Muratori, P., Muratori, L., Carpenter, H. A., & Bianchi, F. B. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.0924.x · Cited by 89
Self-citation
Cited by
Diagnosis and management of autoimmune hepatitis
Manns, M. P., Czaja, A. J., Gorham, J. D., Krawitt, E. L., Mieli-Vergani, G., Vergani, D., & Vierling, J. M. (2010) · Hepatology · doi:10.1002/hep.23584 · Cited by 1,442
Self-citationRole of Antioxidants and Natural Products in Inflammation
Arulselvan, P., Fard, M. T., Tan, W. S., Gothai, S., Fakurazi, S., Norhaizan, M. E., & Kumar, S. S. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/5276130 · Cited by 1,005
Demetris, A. J., Bellamy, C., Hübscher, S. G., O’Leary, J., Randhawa, P. S., Feng, S., Neil, D., Colvin, R. B., McCaughan, G., Fung, J. J., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13909 · Cited by 650
Self-citationManns, M. P., Woynarowski, M., Kreisel, W., Lurie, Y., Rust, C., Zuckerman, E., Bahr, M. J., Günther, R., Hultcrantz, R. W., Spengler, U., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.046 · Cited by 442
Self-citationHepatic inflammation and progressive liver fibrosis in chronic liver disease
Czaja, A. J. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2515 · Cited by 342
Self-citation
Metadata
- Authors
- Czaja, A. J., & Manns, M. P.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 139
- Issue
- 1
- Pages
- 58-72.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2148095358
- Cited by
- 280
- References
- 296
- FWCI
- 19.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.